Banner

Visus CEO updates on lead product candidate, 2021 pipeline

Video
Conferences|AAO

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.


See more AAO coverage here

Related Videos
Related Content

Creating a positive patient financial journey for refractive error procedures

September 18th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Standardizing terminology for clarity in refractive surgery

August 30th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: Pharmacologic treatments for correcting presbyopia

August 25th 2023

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023

Creating a positive patient financial journey for refractive error procedures

September 18th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Standardizing terminology for clarity in refractive surgery

August 30th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: Pharmacologic treatments for correcting presbyopia

August 25th 2023

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023

Creating a positive patient financial journey for refractive error procedures

September 18th 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Standardizing terminology for clarity in refractive surgery

August 30th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: Pharmacologic treatments for correcting presbyopia

August 25th 2023

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023
© 2023 MJH Life Sciences

All rights reserved.